Paul Tudor Jones’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-97,900
Closed -$710K 4369
2026
Q1
$710K Buy
+97,900
New +$1.28M ﹤0.01% 2599
2025
Q2
Sell
-76,926
Closed -$622K 3835
2025
Q1
$622K Buy
+76,926
New +$841K ﹤0.01% 2140
2024
Q4
Sell
-15,202
Closed -$125K 3576
2024
Q3
$125K Buy
+15,202
New +$90.9K ﹤0.01% 2577
2024
Q1
Sell
-36,580
Closed -$185K 2851
2023
Q4
$185K Buy
+36,580
New +$196K ﹤0.01% 2213
2023
Q3
Sell
-42,217
Closed -$154K 2940
2023
Q2
$154K Hold
42,217
﹤0.01% 2264
2023
Q1
$183K Sell
42,217
-382
-0.9% -$1.75K ﹤0.01% 2195
2022
Q4
$298K Sell
42,599
-553
-1% -$2.55K 0.01% 1908
2022
Q3
$156K Hold
43,152
﹤0.01% 2117
2022
Q2
$140K Hold
43,152
﹤0.01% 1887
2022
Q1
$86K Buy
43,152
+13,857
+47% +$33.9K ﹤0.01% 1844
2021
Q4
$92K Buy
29,295
+1,058
+4% +$4.39K ﹤0.01% 2238
2021
Q3
$138K Buy
+28,237
New +$171K ﹤0.01% 2346
2021
Q2
Sell
-46,025
Closed -$258K 1982
2021
Q1
$258K Buy
+46,025
New +$442K 0.01% 1353
2020
Q4
Sell
-53,967
Closed -$458K 1669
2020
Q3
$458K Buy
+53,967
New +$592K 0.02% 851
2019
Q1
Sell
-9,840
Closed -$414K 1297
2018
Q4
$414K Sell
9,840
-3,558
-27% -$158K 0.01% 659
2018
Q3
$670K Buy
+13,398
New +$605K 0.02% 588

Other funds holding WVE

Paul Tudor Jones's WVE Position: Q2 2026 in Review

Paul Tudor Jones sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 97,900 shares — an estimated $710K sold.

Paul Tudor Jones first reported a position in WVE in Q3 2018 and held it in 16 quarters. The position peaked at $710K in Q1 2026. 238 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Paul Tudor Jones reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 97,900 Wave Life Sciences shares in Q2 2026, an estimated $710K.
  • Paul Tudor Jones first reported a position in Wave Life Sciences in Q3 2018 and held it in 16 quarters.
  • Paul Tudor Jones's Wave Life Sciences position peaked at $710K in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.